Matinas Biopharma Holdings Inc (MTNB)

Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten

Taking on analysts' expectations and winning: Matinas Biopharma Holdings Inc (MTNB) – Sete News - SETE News

SETE News

Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin

GlobeNewswire Inc.

Market Watch: Matinas Biopharma Holdings Inc (MTNB)'s Noteworthy Drop, Closing at 0.16 – DWinneX - The Dwinnex

The Dwinnex

Matinas Biopharma Holdings Inc (MTNB)'s stock performance: a year in review – US Post News - US Post News

US Post News

Matinas BioPharma (MTNB) in Focus: Stock Moves 6% Higher - Yahoo Movies UK

Yahoo Movies UK

Its Stock Has Paid Off Big Time For Matinas Biopharma Holdings Inc – Sete News - SETE News

SETE News

Matinas Biopharma Holdings Inc (MTNB): Hold On When You're Right – Stocks Register - Stocks Register

Stocks Register

Adversity is less terrifying than hope: Matinas Biopharma Holdings Inc (MTNB) – Sete News - SETE News

SETE News

Private Advisor Group LLC Boosts Stock Position in Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB) - Defense World

Defense World

A new trading data show Matinas Biopharma Holdings Inc (MTNB) is showing positive returns. – Sete News - SETE News

SETE News

How did Matinas Biopharma Holdings Inc (MTNB) fare last session? – US Post News - US Post News

US Post News

MTNB’s Stock Journey: What Investors Need to Know About Matinas Biopharma Holdings Inc’s Performance - The InvestChronicle

The InvestChronicle

Quarterly Snapshot: Quick and Current Ratios for Matinas Biopharma Holdings Inc (MTNB) – DWinneX - The Dwinnex

The Dwinnex

New In Vitro Data Showing Matinas BioPharma's LNC Platform - GlobeNewswire

GlobeNewswire

New In Vitro Data Showing Matinas BioPharma's LNC Platform Delivering Small Oligonucleotides Presented at TIDES ... - Yahoo Finance

Yahoo Finance

New In Vitro Data Showing Matinas BioPharma's LNC Platform Delivering Small Oligonucleotides Presented at TIDES ... - Yahoo Finance

Yahoo Finance

Will Matinas BioPharma Continue to Surge Higher? - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

A better buy-in window may exist right now for Matinas Biopharma Holdings Inc (MTNB) – Sete News - SETE News

SETE News

Is it possible to buy Matinas Biopharma Holdings Inc(MTNB) shares at a good price now? – US Post News - US Post News

US Post News

After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Matinas Biopharma Holdings, Inc. (MTNB) - Yahoo News UK

Yahoo News UK

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q1 2024 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q1 2024 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire

GlobeNewswire

Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire

GlobeNewswire

Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update - Yahoo Finance

Yahoo Finance

Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update - Yahoo Finance

Yahoo Finance

Matinas Biopharma Holdings, Inc. (MTNB) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Movies Canada

Yahoo Movies Canada

Matinas BioPharma's LNC Platform for the Delivery of Small - GlobeNewswire

GlobeNewswire

Matinas BioPharma's LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ... - Yahoo Finance

Yahoo Finance

Matinas BioPharma's LNC Platform for the Delivery of Small - GlobeNewswire

GlobeNewswire

Matinas BioPharma (MTNB) in Focus: Stock Moves 6% Higher - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

GlobeNewswire Inc.

In Vivo Efficacy of Matinas BioPharma's Oral MAT2203 in - GlobeNewswire

GlobeNewswire

In Vivo Efficacy of Matinas BioPharma's Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of ... - Yahoo Finance

Yahoo Finance

Daily Progress: Matinas Biopharma Holdings Inc (MTNB) Drop -1.43, Closing at 0.18 – DWinneX - The Dwinnex

The Dwinnex

Matinas BioPharma's Multi-Million Share Sale and Lock-Up Deal - TipRanks.com - TipRanks

TipRanks

Matinas BioPharma's Multi-Million Share Sale and Lock-Up Deal - TipRanks.com - TipRanks

TipRanks

Matinas BioPharma Prices $10 Million Registered Direct Offering

GlobeNewswire Inc.

Matinas BioPharma Prices $10 Million Registered Direct Offering - GlobeNewswire

GlobeNewswire

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Matinas BioPharma Updates Presentation for Investor Outreach - TipRanks.com - TipRanks

TipRanks

Matinas BioPharma Holdings, Inc. (MTNB) Q4 2023 Earnings Call Transcript - Seeking Alpha

Seeking Alpha

Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update

GlobeNewswire Inc.

Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update - Yahoo Finance

Yahoo Finance

Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

GlobeNewswire Inc.

Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation - GlobeNewswire

GlobeNewswire

Matinas BioPharma’s MAT2203 Shows Promising Clinical Results - TipRanks

TipRanks

Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response

GlobeNewswire Inc.

Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards

GlobeNewswire Inc.